Nurix Therapeutics, Inc. Quarterly Operating Lease, Liability, Current in USD from Q4 2020 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary: Nurix Therapeutics, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q4 2020 to Q1 2025.
Nurix Therapeutics, Inc. Operating Lease, Liability, Current for the quarter ending February 28, 2025 was $6.64M, a 9.18% decline year-over-year.

Operating Lease, Liability, Current, Quarterly (USD)

Operating Lease, Liability, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2025	$6.64M	-$671K	-9.18%	Feb 28, 2025	10-Q	2025-04-08
Q4 2024	$8.01M	+$525K	+7.01%	Nov 30, 2024	10-Q	2025-04-08
Q3 2024	$6.55M	+$1.19M	+22.2%	Aug 31, 2024	10-Q	2024-10-11
Q2 2024	$7.93M	+$2.35M	+42.1%	May 31, 2024	10-Q	2024-07-11
Q1 2024	$7.31M	+$1.75M	+31.6%	Feb 29, 2024	10-Q	2024-04-10
Q4 2023	$7.49M	+$1.96M	+35.4%	Nov 30, 2023	10-K	2025-01-28
Q3 2023	$5.36M	-$134K	-2.44%	Aug 31, 2023	10-Q	2023-10-12
Q2 2023	$5.58M	+$113K	+2.07%	May 31, 2023	10-Q	2023-07-13
Q1 2023	$5.56M	+$126K	+2.32%	Feb 28, 2023	10-Q	2023-04-13
Q4 2022	$5.53M	+$1.68M	+43.7%	Nov 30, 2022	10-K	2024-02-15
Q3 2022	$5.5M			Aug 31, 2022	10-Q	2022-10-06
Q2 2022	$5.47M			May 31, 2022	10-Q	2022-07-07
Q1 2022	$5.43M			Feb 28, 2022	10-Q	2022-04-08
Q4 2021	$3.85M	+$505K	+15.1%	Nov 30, 2021	10-K	2023-02-09
Q4 2020	$3.34M			Dec 1, 2020	10-Q	2022-10-06

Showing 1 to 15 of 15 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.